Integrity Applications appoints Paul Goode as President and COO effective Nov 1, 2021

Glucotrack, Inc.

Paul V. Goode appointed President and COO effective November 1, 2021; steps down from Board.
Base salary of $175,000/year; eligible for cash bonus up to 20% of base salary.
Granted options to purchase 1.5% of fully diluted common stock at exercise price ≥ $5.20, vesting over 3 years.
Goode most recently VP of Product Development at Orchestra Biomed; will lead U.S. infrastructure for GlucoTrack trials.
Employment agreement includes standard termination provisions and financial-misstatement clawback.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul V. Goode

President and Chief Operating Officer

GCTK · Glucotrack, Inc.

Effective: 2021-11-01
Filed: October 25, 2021, 7:59 PM ET

On October 19, 2021, Paul V. Goode was appointed as President and Chief Operating Officer of Integrity Applications, Inc. (the “Company”), effective November 1, 2021 (“Effective Date”).

Departed

Paul V. Goode

Director

GCTK · Glucotrack, Inc.

Effective: 2021-11-01
Filed: October 25, 2021, 7:59 PM ET

Concurrent with his new appointment, Mr. Goode will be stepping down from the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul V. Goode was appointed as President and Chief Operating Officer at Glucotrack, Inc..

Action: appointed
Role: President and Chief Operating Officer

Exact text from the filing

On October 19, 2021, Paul V. Goode was appointed as President and Chief Operating Officer of Integrity Applications, Inc. (the “Company”), effective November 1, 2021 (“Effective Date”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul V. Goode departed as Director at Glucotrack, Inc..

Action: stepping down
Role: Director

Exact text from the filing

Concurrent with his new appointment, Mr. Goode will be stepping down from the Board.

View on SEC.gov

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-026238

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.